nodes	percent_of_prediction	percent_of_DWPC	metapath
Liothyronine—SLCO4C1—Methotrexate—bone cancer	0.288	0.319	CbGbCtD
Liothyronine—SLCO1C1—Methotrexate—bone cancer	0.202	0.224	CbGbCtD
Liothyronine—SLCO1B3—Methotrexate—bone cancer	0.113	0.125	CbGbCtD
Liothyronine—SLCO1A2—Methotrexate—bone cancer	0.0697	0.0772	CbGbCtD
Liothyronine—SLCO1B1—Methotrexate—bone cancer	0.0658	0.0729	CbGbCtD
Liothyronine—SLC22A8—Methotrexate—bone cancer	0.0607	0.0673	CbGbCtD
Liothyronine—ALB—Methotrexate—bone cancer	0.036	0.0399	CbGbCtD
Liothyronine—ABCB1—Cisplatin—bone cancer	0.029	0.0322	CbGbCtD
Liothyronine—ABCB1—Doxorubicin—bone cancer	0.0194	0.0215	CbGbCtD
Liothyronine—ABCB1—Methotrexate—bone cancer	0.0188	0.0209	CbGbCtD
Liothyronine—SERPINA7—vertebral column—bone cancer	0.0109	0.334	CbGeAlD
Liothyronine—TTR—vertebral column—bone cancer	0.00501	0.153	CbGeAlD
Liothyronine—SLC10A1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00474	0.0732	CbGpPWpGaD
Liothyronine—THRB—Nuclear Receptors—NR1I2—bone cancer	0.00354	0.0546	CbGpPWpGaD
Liothyronine—THRA—Nuclear Receptors—NR1I2—bone cancer	0.00354	0.0546	CbGpPWpGaD
Liothyronine—THRB—SIDS Susceptibility Pathways—FEV—bone cancer	0.00338	0.0521	CbGpPWpGaD
Liothyronine—THRB—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.0028	0.0431	CbGpPWpGaD
Liothyronine—THRA—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.0028	0.0431	CbGpPWpGaD
Liothyronine—SLC10A1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00277	0.0428	CbGpPWpGaD
Liothyronine—SLC10A1—Farnesoid X Receptor  Pathway—CYP3A4—bone cancer	0.00254	0.0391	CbGpPWpGaD
Liothyronine—SLCO1B1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00213	0.0329	CbGpPWpGaD
Liothyronine—SLCO1B1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.002	0.0308	CbGpPWpGaD
Liothyronine—SERPINA7—bone marrow—bone cancer	0.00153	0.0467	CbGeAlD
Liothyronine—SERPINA7—spinal cord—bone cancer	0.00152	0.0465	CbGeAlD
Liothyronine—THRA—Generic Transcription Pathway—ZNF77—bone cancer	0.00143	0.022	CbGpPWpGaD
Liothyronine—THRB—Generic Transcription Pathway—ZNF77—bone cancer	0.00143	0.022	CbGpPWpGaD
Liothyronine—THRA—connective tissue—bone cancer	0.00142	0.0434	CbGeAlD
Liothyronine—SLCO1B1—Irinotecan Pathway—CYP3A4—bone cancer	0.00136	0.021	CbGpPWpGaD
Liothyronine—SLCO1B1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00117	0.018	CbGpPWpGaD
Liothyronine—THRA—Endochondral Ossification—IGF1R—bone cancer	0.0011	0.0169	CbGpPWpGaD
Liothyronine—SLC7A5—connective tissue—bone cancer	0.00108	0.0331	CbGeAlD
Liothyronine—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00107	0.0165	CbGpPWpGaD
Liothyronine—TTR—connective tissue—bone cancer	0.00105	0.0322	CbGeAlD
Liothyronine—TTR—Extracellular matrix organization—PLOD2—bone cancer	0.00102	0.0157	CbGpPWpGaD
Liothyronine—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000999	0.0154	CbGpPWpGaD
Liothyronine—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000997	0.0154	CbGpPWpGaD
Liothyronine—SLCO4C1—bone marrow—bone cancer	0.000986	0.0301	CbGeAlD
Liothyronine—THRB—tendon—bone cancer	0.000976	0.0298	CbGeAlD
Liothyronine—THRA—tendon—bone cancer	0.000976	0.0298	CbGeAlD
Liothyronine—ALB—Folate Metabolism—FOLR1—bone cancer	0.000968	0.0149	CbGpPWpGaD
Liothyronine—THRA—spinal cord—bone cancer	0.000941	0.0287	CbGeAlD
Liothyronine—THRA—Endochondral Ossification—PLAU—bone cancer	0.000893	0.0138	CbGpPWpGaD
Liothyronine—SLCO1C1—spinal cord—bone cancer	0.000782	0.0239	CbGeAlD
Liothyronine—SLC7A5—tendon—bone cancer	0.000744	0.0227	CbGeAlD
Liothyronine—SLC7A5—bone marrow—bone cancer	0.000721	0.022	CbGeAlD
Liothyronine—SLC7A5—spinal cord—bone cancer	0.000718	0.0219	CbGeAlD
Liothyronine—TTR—bone marrow—bone cancer	0.000702	0.0215	CbGeAlD
Liothyronine—TTR—spinal cord—bone cancer	0.000699	0.0214	CbGeAlD
Liothyronine—THRB—Gene Expression—ZNF77—bone cancer	0.000687	0.0106	CbGpPWpGaD
Liothyronine—THRA—Gene Expression—ZNF77—bone cancer	0.000687	0.0106	CbGpPWpGaD
Liothyronine—SLCO4A1—spinal cord—bone cancer	0.000627	0.0192	CbGeAlD
Liothyronine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000603	0.0093	CbGpPWpGaD
Liothyronine—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000584	0.00901	CbGpPWpGaD
Liothyronine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000574	0.00885	CbGpPWpGaD
Liothyronine—SLC16A10—tendon—bone cancer	0.00057	0.0174	CbGeAlD
Liothyronine—THRA—Endochondral Ossification—MMP9—bone cancer	0.000529	0.00817	CbGpPWpGaD
Liothyronine—TTR—Extracellular matrix organization—LOX—bone cancer	0.000503	0.00776	CbGpPWpGaD
Liothyronine—THRA—Generic Transcription Pathway—NR1I2—bone cancer	0.000483	0.00745	CbGpPWpGaD
Liothyronine—THRB—Generic Transcription Pathway—NR1I2—bone cancer	0.000483	0.00745	CbGpPWpGaD
Liothyronine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000474	0.00731	CbGpPWpGaD
Liothyronine—SLCO1A2—spinal cord—bone cancer	0.000449	0.0137	CbGeAlD
Liothyronine—SLCO4C1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00044	0.00679	CbGpPWpGaD
Liothyronine—SLCO4A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00044	0.00679	CbGpPWpGaD
Liothyronine—SLC7A5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000403	0.00621	CbGpPWpGaD
Liothyronine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—bone cancer	0.000397	0.00613	CbGpPWpGaD
Liothyronine—SLCO4A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00038	0.00586	CbGpPWpGaD
Liothyronine—SLCO4C1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00038	0.00586	CbGpPWpGaD
Liothyronine—TTR—Extracellular matrix organization—SPARC—bone cancer	0.000377	0.00581	CbGpPWpGaD
Liothyronine—SLCO1C1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000369	0.00569	CbGpPWpGaD
Liothyronine—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000352	0.00543	CbGpPWpGaD
Liothyronine—SLC7A5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000348	0.00536	CbGpPWpGaD
Liothyronine—THRA—Gene Expression—FUS—bone cancer	0.000335	0.00518	CbGpPWpGaD
Liothyronine—THRB—Gene Expression—FUS—bone cancer	0.000335	0.00518	CbGpPWpGaD
Liothyronine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000335	0.00517	CbGpPWpGaD
Liothyronine—SLCO1C1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000318	0.00491	CbGpPWpGaD
Liothyronine—SLC16A10—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000268	0.00413	CbGpPWpGaD
Liothyronine—SLC7A5—Hemostasis—SPARC—bone cancer	0.000267	0.00412	CbGpPWpGaD
Liothyronine—THRB—SIDS Susceptibility Pathways—JUN—bone cancer	0.000267	0.00412	CbGpPWpGaD
Liothyronine—ALB—Folate Metabolism—DHFR—bone cancer	0.000266	0.0041	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—NDUFA12—bone cancer	0.000261	0.00402	CbGpPWpGaD
Liothyronine—SLC7A5—Hemostasis—GNA11—bone cancer	0.000244	0.00377	CbGpPWpGaD
Liothyronine—ALB—Platelet degranulation—SPARC—bone cancer	0.000233	0.00359	CbGpPWpGaD
Liothyronine—THRA—Gene Expression—NR1I2—bone cancer	0.000232	0.00359	CbGpPWpGaD
Liothyronine—THRB—Gene Expression—NR1I2—bone cancer	0.000232	0.00359	CbGpPWpGaD
Liothyronine—SLC16A10—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000231	0.00356	CbGpPWpGaD
Liothyronine—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000222	0.00342	CbGpPWpGaD
Liothyronine—SLC7A5—Hemostasis—IL3—bone cancer	0.000221	0.00342	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—NT5C3A—bone cancer	0.000216	0.00333	CbGpPWpGaD
Liothyronine—SLCO1B3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000209	0.00322	CbGpPWpGaD
Liothyronine—SLC22A8—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000185	0.00285	CbGpPWpGaD
Liothyronine—SLCO1B3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00018	0.00278	CbGpPWpGaD
Liothyronine—THRA—Gene Expression—EIF2S1—bone cancer	0.000172	0.00265	CbGpPWpGaD
Liothyronine—THRB—Gene Expression—EIF2S1—bone cancer	0.000172	0.00265	CbGpPWpGaD
Liothyronine—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000164	0.00253	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—NDUFA12—bone cancer	0.000163	0.00252	CbGpPWpGaD
Liothyronine—TTR—Extracellular matrix organization—MMP2—bone cancer	0.000162	0.00249	CbGpPWpGaD
Liothyronine—SLC22A8—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00016	0.00246	CbGpPWpGaD
Liothyronine—ABCB1—bone marrow—bone cancer	0.000151	0.00461	CbGeAlD
Liothyronine—ABCB1—spinal cord—bone cancer	0.00015	0.00459	CbGeAlD
Liothyronine—THRB—Gene Expression—EZH2—bone cancer	0.000149	0.0023	CbGpPWpGaD
Liothyronine—THRA—Gene Expression—EZH2—bone cancer	0.000149	0.0023	CbGpPWpGaD
Liothyronine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000146	0.00225	CbGpPWpGaD
Liothyronine—SLC7A5—Hemostasis—PLAU—bone cancer	0.000145	0.00224	CbGpPWpGaD
Liothyronine—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000142	0.00219	CbGpPWpGaD
Liothyronine—SLCO1B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00014	0.00217	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—NT5C3A—bone cancer	0.000135	0.00209	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—NDUFA12—bone cancer	0.000128	0.00198	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—RGS1—bone cancer	0.000124	0.00192	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—GRM4—bone cancer	0.000124	0.00192	CbGpPWpGaD
Liothyronine—TTR—Extracellular matrix organization—MMP9—bone cancer	0.000121	0.00187	CbGpPWpGaD
Liothyronine—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000121	0.00187	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.00012	0.00184	CbGpPWpGaD
Liothyronine—TTR—Disease—ENO2—bone cancer	0.000114	0.00176	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—NDUFA12—bone cancer	0.00011	0.00169	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—GRM1—bone cancer	0.000108	0.00166	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—NT5C3A—bone cancer	0.000106	0.00164	CbGpPWpGaD
Liothyronine—TTR—Disease—DHFR—bone cancer	0.000106	0.00164	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000103	0.00159	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000102	0.00157	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—ENO2—bone cancer	9.47e-05	0.00146	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	9.44e-05	0.00146	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	9.26e-05	0.00143	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—NT5C3A—bone cancer	9.09e-05	0.0014	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—DHFR—bone cancer	8.78e-05	0.00136	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	8.56e-05	0.00132	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	8.43e-05	0.0013	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	8.31e-05	0.00128	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—GNA11—bone cancer	8.21e-05	0.00127	CbGpPWpGaD
Liothyronine—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.02e-05	0.00124	CbGpPWpGaD
Liothyronine—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	7.92e-05	0.00122	CbGpPWpGaD
Liothyronine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	7.88e-05	0.00122	CbGpPWpGaD
Liothyronine—TTR—Disease—TGFBR2—bone cancer	7.69e-05	0.00119	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—SMO—bone cancer	7.59e-05	0.00117	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—CYP3A4—bone cancer	7.44e-05	0.00115	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.4e-05	0.00114	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.05e-05	0.00109	CbGpPWpGaD
Liothyronine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.03e-05	0.00108	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—GNA11—bone cancer	6.94e-05	0.00107	CbGpPWpGaD
Liothyronine—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.92e-05	0.00107	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—ATF1—bone cancer	6.45e-05	0.000996	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—GSTP1—bone cancer	6.36e-05	0.000982	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—IL3—bone cancer	6.29e-05	0.000971	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NDUFA12—bone cancer	6.27e-05	0.000967	CbGpPWpGaD
Liothyronine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.07e-05	0.000936	CbGpPWpGaD
Liothyronine—ALB—Folate Metabolism—TP53—bone cancer	5.94e-05	0.000916	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—ENO2—bone cancer	5.93e-05	0.000915	CbGpPWpGaD
Liothyronine—SLC7A5—Hemostasis—TP53—bone cancer	5.84e-05	0.000901	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—DHFR—bone cancer	5.5e-05	0.000849	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NDUFA12—bone cancer	5.49e-05	0.000848	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—TGFBR2—bone cancer	5.38e-05	0.00083	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—SPARC—bone cancer	5.32e-05	0.000821	CbGpPWpGaD
Liothyronine—TTR—Disease—KIT—bone cancer	5.24e-05	0.000809	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.22e-05	0.000806	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NT5C3A—bone cancer	5.2e-05	0.000802	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—GNA11—bone cancer	5.14e-05	0.000793	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—IGF1R—bone cancer	5.06e-05	0.000781	CbGpPWpGaD
Liothyronine—TTR—Disease—BRAF—bone cancer	4.93e-05	0.000761	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—GNA11—bone cancer	4.87e-05	0.000751	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—CYP3A4—bone cancer	4.66e-05	0.000719	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—ENO2—bone cancer	4.66e-05	0.000719	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.64e-05	0.000715	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NT5C3A—bone cancer	4.55e-05	0.000702	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—IL3—bone cancer	4.41e-05	0.000681	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—DHFR—bone cancer	4.32e-05	0.000667	CbGpPWpGaD
Liothyronine—TTR—Disease—MDM2—bone cancer	4.13e-05	0.000637	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—GNA11—bone cancer	4.04e-05	0.000623	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—GSTP1—bone cancer	3.99e-05	0.000615	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—ENO2—bone cancer	3.98e-05	0.000615	CbGpPWpGaD
Liothyronine—TTR—Disease—PTGS2—bone cancer	3.98e-05	0.000614	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.87e-05	0.000598	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.73e-05	0.000576	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—DHFR—bone cancer	3.69e-05	0.00057	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—KIT—bone cancer	3.67e-05	0.000567	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—CYP3A4—bone cancer	3.66e-05	0.000565	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.64e-05	0.000562	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—GNA11—bone cancer	3.45e-05	0.000533	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—BRAF—bone cancer	3.45e-05	0.000533	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.37e-05	0.00052	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—PTGS2—bone cancer	3.3e-05	0.000509	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—GSTP1—bone cancer	3.13e-05	0.000483	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—CYP3A4—bone cancer	3.13e-05	0.000483	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.11e-05	0.000481	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PLAU—bone cancer	2.89e-05	0.000447	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MDM2—bone cancer	2.89e-05	0.000446	CbGpPWpGaD
Liothyronine—TTR—Disease—EGFR—bone cancer	2.82e-05	0.000435	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—GSTP1—bone cancer	2.68e-05	0.000413	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.65e-05	0.000408	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—JUN—bone cancer	2.51e-05	0.000388	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MMP9—bone cancer	2.45e-05	0.000377	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ENO2—bone cancer	2.28e-05	0.000351	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.22e-05	0.000343	CbGpPWpGaD
Liothyronine—ALB—Metabolism—DHFR—bone cancer	2.11e-05	0.000326	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PTGS2—bone cancer	2.06e-05	0.000319	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ENO2—bone cancer	1.99e-05	0.000308	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—EGFR—bone cancer	1.98e-05	0.000305	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GNA11—bone cancer	1.97e-05	0.000304	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—DHFR—bone cancer	1.85e-05	0.000285	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP3A4—bone cancer	1.79e-05	0.000276	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.78e-05	0.000275	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GNA11—bone cancer	1.73e-05	0.000267	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—TP53—bone cancer	1.66e-05	0.000256	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PTGS2—bone cancer	1.62e-05	0.00025	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP3A4—bone cancer	1.57e-05	0.000242	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTP1—bone cancer	1.53e-05	0.000236	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PTGS2—bone cancer	1.39e-05	0.000214	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTP1—bone cancer	1.34e-05	0.000207	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—TP53—bone cancer	1.16e-05	0.00018	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PTGS2—bone cancer	7.93e-06	0.000122	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PTGS2—bone cancer	6.94e-06	0.000107	CbGpPWpGaD
